Serum alkaline phosphatase (AP) is an important marker of cholestasis, a condition in which the normal flow of bile from the liver is interrupted. Cholestasis may result from physical obstruction of the biliary tree (extrahepatic cholestasis), or from poorly understood mechanisms in which bile flow is interrupted at the cellular or sub-cellular level (intrahepatic cholestasis). Irrespective of the type of cholestasis, AP activity in the liver and circulation are uniformly increased. As most of the AP in the liver is found on the canalicular membrane, it is not clear how the enzyme gets into the circulation. Two possible explanations exist: a secreted form of the enzyme might be synthesized de novo, or membrane-anchored AP may migrate along the intercellular space towards the sinusoidal membrane where it is cleaved by phospholipase C. These two theories are not mutually exclusive. This proposal aims at answering some of the questions related to AP synthesis and secretion by the liver. Specifically, the studies will focus on: 1. Whether a secreted form of AP is synthesized by the liver. 2. How the increased synthesis of AP is mediated. 3. The process of AP attachment to the microsomal membrane. The techniques that will be used include histochemical staining of liver sections affinity chromatography, in vitro transcription and translation, Northern blots, tissue culture and precursor labeling. The significance of the work lies in gaining an understanding into the process of AP synthesis as it relates to the liver in normal and diseased states.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
1R29DK039552-01A1
Application #
3463210
Study Section
Pathobiochemistry Study Section (PBC)
Project Start
1989-01-01
Project End
1993-12-31
Budget Start
1989-01-01
Budget End
1989-12-31
Support Year
1
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Type
Schools of Medicine
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Sussman, N L; Finegold, M J; Barish, J P et al. (1994) A case of syncytial giant-cell hepatitis treated with an extracorporeal liver assist device. Am J Gastroenterol 89:1077-82
Gislason, G T; Lobdell, D D; Kelly, J H et al. (1994) A treatment system for implementing an extracorporeal liver assist device. Artif Organs 18:385-9
Sussman, N L; Gislason, G T; Kelly, J H (1994) Extracorporeal liver support. Application to fulminant hepatic failure. J Clin Gastroenterol 18:320-4
Sussman, N L; Kelly, J H (1993) Extracorporeal liver assist in the treatment of fulminant hepatic failure. Blood Purif 11:170-4
Sussman, N L; Kelly, J H (1993) Improved liver function following treatment with an extracorporeal liver assist device. Artif Organs 17:27-30
Kelly, J H; Koussayer, T; He, D et al. (1992) Assessment of an extracorporeal liver assist device in anhepatic dogs. Artif Organs 16:418-22
Sussman, N L; Chong, M G; Koussayer, T et al. (1992) Reversal of fulminant hepatic failure using an extracorporeal liver assist device. Hepatology 16:60-5
Kelly, J H; Koussayer, T; He, D E et al. (1992) An improved model of acetaminophen-induced fulminant hepatic failure in dogs. Hepatology 15:329-35